Advagraf de novo in liver transplantation: A single-center experience

Transplantation Proceedings

Volumn 43, Issue 3, 2011, Pages 724-725

  Ortiz De Urbina, J ^a   Valdivieso, A ^a   Matarranz, A ^a   Gastaca, M ^a   Fernandez, J R ^a   Bustamante, J ^a   Gonzalez, J ^a   Ventoso, A ^a   Testillano, M ^a   Ruiz, P ^a   Suarez, M ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; GLYCEMIC CONTROL; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FUNCTION; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MORNING DOSAGE; NEUROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT;

CREATININE; DIABETES MELLITUS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LIVER TRANSPLANTATION; TACROLIMUS;

EID: 79954546966     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.089     Document Type: Conference Paper

References (4)

1. S. Florman, R. Alloway, and M. Kalayoglu Conversion of stable liver transplant recipients from a twice-daily-Prograf-based regimen to a once-daily modified release tacrolimus-based regimen Transplant Proc 37 2005 1211
2. Surez MA, Snchez B, Fernndez JL,, et al. Estudio prospectivo para valorar la eficacia de Advagraf en trasplantados hepticos de novo [abstract]. XXI Congreso SETH.
3. P. Truneka, O. Boillot, and D. Seehofer Once-daily prolonged release tacrolimus (Advagraf) versus twice-daily tacrolimus (Prograf) in liver transplantation Am J Transplant 10 2010 1
4. ®) in the novo liver transplant recipients in a phase III multicentre study Transplantation 86 suppl 2 2008 127